SMTL ID : 3ml9.1

Discovery of the Highly Potent PI3K/mTOR Dual Inhibitor PF-04691502 through Structure Based Drug Design

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.55 Å

Oligo State

monomer

Ligands

1 x ML9: 2-amino-8-[trans-4-(2-hydroxyethoxy)cyclohexyl]-6-(6-methoxypyridin-3-yl)-4-methylpyrido[2,3-d]pyrimidin-7(8H)-one(Non-covalent)

ML9.1: 16 residues within 4Å: Chain A: M.662, W.670, I.689, K.691, D.694, D.699, Y.725, I.737, E.738, I.739, V.740, A.743, T.745, K.748, M.811, D.822 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:W.670, A:Y.725, A:I.737, A:V.740 Hydrogen bonds: A:K.691, A:V.740, A:A.743, A:K.748, A:K.748, A:D.822

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Cheng, H. et al., Discovery of the Highly Potent PI3K/mTOR Dual Inhibitor PF-04979064 through Structure-Based Drug Design. ACS Med Chem Lett (2013)

Release Date

2010-06-02

Peptides

Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform

Related Entries With Identical Sequence